Recently, the Sichuan Provincial Medical Insurance Administration issued a notice officially incorporating brain-computer interface (BCI)-related medical services into its pricing management framework, making Sichuan the first province in China to establish official pricing for clinical BCI applications. This move marks a significant step toward the standardized clinical translation and regulation of cutting-edge medical technologies in the country.According to the notice, BCI technologies are categorized into invasive and non-invasive types, with specific service codes and fee standards set for different clinical applications—such as neurorehabilitation and assistive control for paralyzed patients. For instance, a single session of non-invasive BCI therapy for motor dysfunction rehabilitation is priced at approximately ¥800, while invasive procedures, due to their complexity and higher risks, carry significantly higher costs and require strict regulatory approval before implementation.This policy not only helps standardize hospital billing practices and prevent unnecessary treatments but also provides patients with clearer and more predictable cost expectations. Moreover, a transparent pricing system is expected to accelerate the clinical adoption of BCI technology and foster collaboration among industry, academia, and healthcare providers. Experts suggest that as the technology matures and costs decline, BCI could become a vital tool in treating neurological disorders.Sichuan’s pilot initiative offers valuable insights for developing national standards and signals strong governmental support for bringing innovative medical technologies into real-world clinical practice.
近日，四川省医保局发布通知，明确将脑机接口（Brain-Computer Interface, BCI）相关医疗服务纳入价格管理范围，成为全国首个对脑机接口医疗应用制定官方定价的省份。此举标志着我国在推动前沿医疗技术临床转化和规范化管理方面迈出关键一步。根据通知，四川将脑机接口技术分为侵入式与非侵入式两类，并针对不同应用场景（如神经康复、瘫痪患者辅助控制等）设定了具体的服务项目编码和收费标准。例如，非侵入式脑机接口用于运动功能障碍康复的单次治疗价格约为800元，而侵入式技术因操作复杂、风险较高，费用则显著更高，需经严格审批后方可开展。这一政策不仅有助于规范医疗机构收费行为，防止过度医疗，也为患者提供了更透明、可预期的费用参考。同时，明确的价格体系有望加速脑机接口技术在临床中的推广，促进产学研医协同发展。专家指出，随着技术成熟和成本下降，未来脑机接口或将成为神经系统疾病治疗的重要手段。四川此次先行先试，为国家层面制定统一标准积累了宝贵经验，也释放出支持创新医疗技术落地的积极信号。
原创文章，作者：admin，如若转载，请注明出处：https://avine.cn/10718.html